These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 8684023)

  • 1. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
    Tishler S; Hoffman JC
    AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal reaction to gadopentetate dimeglumine.
    Jordan RM; Mintz RD
    AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
    [No Abstract]   [Full Text] [Related]  

  • 4. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
    Witte RJ; Anzai LL
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical safety of gadopentetate dimeglumine.
    Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA
    Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential neurotoxic effects of gadopentetate dimeglumine: clinical significance.
    Alhassan A; Weinmann HJ
    AJNR Am J Neuroradiol; 1997 Apr; 18(4):785-6; author reply 786-8. PubMed ID: 9127052
    [No Abstract]   [Full Text] [Related]  

  • 7. Eye and testicular pain after administration of gadopentetate dimeglumine.
    Padhani AR; Lopez AJ; Revell PB; MacVicar DA
    AJR Am J Roentgenol; 1995 Aug; 165(2):484-5. PubMed ID: 7618587
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe adverse reaction to iv gadopentetate dimeglumine.
    Takebayashi S; Sugiyama M; Nagase M; Matsubara S
    AJR Am J Roentgenol; 1993 Mar; 160(3):659. PubMed ID: 8430574
    [No Abstract]   [Full Text] [Related]  

  • 9. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 10. Can gadolinium be safely given in renal failure?
    Weissleder R
    AJR Am J Roentgenol; 1996 Jul; 167(1):278-9. PubMed ID: 8659405
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gadolinium-DTPA dimeglumine administered orally for the study of the abdomen with magnetic resonance. Clinical evaluation and tolerance].
    Squillaci E; Crecco M; Cecconi L; Lupoi D; Sergiacomi GL; Simonetti G
    Radiol Med; 1993 Sep; 86(3):284-93. PubMed ID: 8210538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylactic shock induced by intravenous gadopentetate dimeglumine.
    Tardy B; Guy C; Barral G; Page Y; Ollagnier M; Bertrand JC
    Lancet; 1992 Feb; 339(8791):494. PubMed ID: 1346846
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized seizure after i.v. administration of gadopentetate dimeglumine.
    Harbury OL
    AJNR Am J Neuroradiol; 1991; 12(4):666. PubMed ID: 1882740
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats.
    Mühler A; Saeed M; Brasch RC; Higgins CB
    Radiology; 1992 May; 183(2):523-8. PubMed ID: 1561362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
    Myhr G; Rinck PA; Børseth A
    Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of gadodiamide injection and gadopentetate dimeglumine in anesthetized dogs.
    Peters JL; Shaw DD
    Acta Radiol; 1993 Sep; 34(5):510-6. PubMed ID: 8369191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
    García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
    Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
    [No Abstract]   [Full Text] [Related]  

  • 18. MR imaging of pituitary region lesions with gadodiamide injection.
    Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
    Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety review of gadopentetate dimeglumine. Extended clinical experience after more than five million applications.
    Niendorf HP; Alhassan A; Geens VR; Clauss W
    Invest Radiol; 1994 Jun; 29 Suppl 2():S179-82. PubMed ID: 7928222
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.